The Current Ratio of BioCryst Pharmaceuticals, Inc. (BCRX) is
2.06.
Current Ratio compares a firm's current assets to its current liabilities to assess short-term liquidity. A ratio above 1.0 typically indicates a strong ability to meet obligations.
| Date |
Value |
| 2025-12-31 |
2.06
|
| 2024-12-31 |
2.63
|
| 2023-12-31 |
3.31
|
| 2022-12-31 |
4.90
|
| 2021-12-31 |
5.46
|
| 2020-12-31 |
3.06
|
| 2019-12-31 |
1.78
|
| 2018-12-31 |
1.65
|
| 2017-12-31 |
1.68
|
| 2016-12-31 |
1.23
|
| Ticker |
Name |
Value |
|
ENTA
|
Enanta Pharmaceuticals Inc
|
4.21
|
|
ZNTL
|
Zentalis Pharmaceuticals, Inc.
|
6.93
|
|
LXRX
|
Lexicon Pharmaceuticals, Inc.
|
4.88
|
|
MGNX
|
MacroGenics Inc
|
5.10
|
|
MORF
|
Morphic Holding Inc
|
28.94
|
|
XNCR
|
Xencor, Inc.
|
6.25
|
|
MDXG
|
MiMedx Group, Inc.
|
4.32
|
|
MGTX
|
MeiraGTx Holdings PLC
|
0.75
|
|
950220.KQ
|
Neoimmunetech Inc
|
3.08
|
|
MNKD
|
MannKind Corporation
|
1.70
|
|
REGN
|
Regeneron Pharmaceuticals, Inc.
|
4.13
|
|
HRTX
|
Heron Therapeutics Inc
|
2.48
|
|
SRNE
|
Sorrento Therapeutics Inc
|
0.29
|
|
SRRK
|
Scholar Rock Holding Corporation
|
6.95
|
|
STRO
|
Sutro Biopharma Inc
|
2.01
|
|
ABBV
|
AbbVie Inc.
|
0.67
|
|
CRIS
|
Curis Inc
|
0.49
|
|
GILD
|
Gilead Sciences, Inc.
|
1.55
|
|
HGEN
|
Humanigen Inc
|
0.20
|
|
VRTX
|
Vertex Pharmaceuticals Incorporated
|
2.90
|
|
CVM
|
CEL-SCI Corp
|
2.26
|
|
EDIT
|
Editas Medicine, Inc.
|
3.54
|
|
RNA
|
Atrium Therapeutics Inc
|
0.07
|
|
ADAG
|
Adagene Inc.
|
3.07
|
|
AMGN
|
Amgen Inc
|
1.14
|
|
CDMO
|
Avid Bioservices Inc
|
1.47
|
|
CLDX
|
Celldex Therapeutics, Inc.
|
10.49
|
|
XENE
|
Xenon Pharmaceuticals Inc.
|
13.42
|
|
950200.KQ
|
Psomagen Inc
|
1.67
|
|
MRNA
|
Moderna, Inc.
|
3.29
|
|
TVTX
|
Travere Therapeutics, Inc.
|
2.74
|
|
VCEL
|
Vericel Corporation
|
5.03
|
|
ORGO
|
Organogenesis Holdings Inc.
|
3.62
|
|
PGEN
|
Precigen, Inc.
|
3.09
|
|
950160.KQ
|
Kolon TissueGene Inc
|
0.24
|
|
KDMN
|
Kadmon Holdings Inc
|
4.65
|
|
MDGL
|
Madrigal Pharmaceuticals, Inc.
|
4.01
|